Otic Flush

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
1000.0%
Death Rate

Active Ingredients

Otic Flush

Administration Routes

UnknownAuricular (Otic)

Species Affected

Dog 9
Cat 1

Most Affected Breeds

Crossbred Canine/dog 2
Maltese 1
Spaniel - Cocker American 1
Domestic Shorthair 1
Retriever - Labrador 1
Shiba Inu 1
Dog (unknown) 1
Terrier - Bull - American Pit 1
Shih Tzu 1

Most Reported Reactions

Lack of efficacy - NOS 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Decreased appetite 2
Other abnormal test result NOS 2
Aggression 2
Application site haemorrhage 2
CULTURE/TITER DATA ABNORMAL 2
Hiding 2
Weight loss 1
Shaking 1
Elevated renal parameters 1
Hyperphosphataemia 1

Outcome Breakdown

Recovered/Normal
4 (40.0%)
Outcome Unknown
3 (30.0%)
Ongoing
2 (20.0%)
Euthanized
1 (10.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 1
Case-fatality rate (reported events) 1000.0%
Distinct species in reports 2
Distinct breeds in reports 9
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Otic Flush Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing Otic Flush, including 1 reports in which the animal died — a 1000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Otic Flush. Reported administration routes include Unknown, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Otic Flush reports are Dog (9 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (2), Maltese (1), Spaniel - Cocker American (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Otic Flush are Lack of efficacy - NOS (3), Lethargy (see also Central nervous system depression in 'Neurological') (3), Decreased appetite (2), Other abnormal test result NOS (2). Of the 10 reports with a coded outcome, Recovered/Normal is the leading category at 40.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Otic Flush.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial